Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion
The author describes the benefits, processes, and practicality of using hot-melt extrusion to mix active pharmaceutical ingredients with pharmaceutical-grade polymers.

Pharmaceutical Technology
Volume 32, Issue 10, pp. 76-86

in which Δ T is the change in temperature in C, and Δ P is the change in pressure (1 bar = 14.503 psi). In addition, the extruder rpm and the geometry of the discharge screw elements can drive the melt temperature even higher.

Feeding systems

Feeders set the throughput rate to the twin-screw extrusion system. The extruder-screw rpm is independent from the feed rate and is used to optimize compounding and devolatilization efficiencies. Feedstocks can be pellets, granules, fibers, powders, and/or liquids. Delivery mechanisms include vibratory trays, belts, single screw, and twin-screws for solids; and piston or gear pumps for liquids. As previously stated, the pressure gradient in the process section of the twin-screw extruder is zero for much of the process, which allows downstream unit operations to be performed.

Figure 9 (All figures are courtesy of the author.)
Loss-in-weight feeders measure the flow rate for the feeder via a precision load cell (see Figure 9). As the feeder discharges material to the extruder, the speed of the delivery mechanism adjusts to maintain the desired feed-rate set point. For loss-in-weight controls to work properly, the feeder must be optimized mechanically with regard to the hopper, auger mechanism, and mounting/interface hardware with the extruder. Multiple feeders facilitate introducing ingredients at different positions along the length of the process section. Material handling and refill systems that integrate the appropriate degree of isolation and containment are integrated into the system design.

The feed rate, in combination with the screws' rpm, is integral to the mixing intensity that the materials experience during the HME process. A high feed rate with a low screws rpm will result in a gentle mixing effect as compared with a low feed rate and high screws rpm. Because the feed rate is independent from the screws rpm, the HSEI twin-screw extruder has a wide operating window.

Downstream operations

A wide variety of downstream systems are available after the extruder. Pellets or shapes may be extruded and wound, or cut to length. Film and lamination systems are used to combine melt extrusion with substrates for transdermal applications.

Figure 10 (All figures are courtesy of the author.)
For any HME process, the melt stream must be converted from the circular shape into the final product. The basic die design needs to account for varying material paths and residence times within the die based upon the extrudate dimensions and materials being processed (see Figure 10). Advanced dies would also have some sort of adjustment to maintain a dimensionally stable product. A variety of end products can be produced via hot-melt extrusion.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here